Clinical Trial Update: Zyprexa® Relprevv™ Patient Care Program

View source ↗

Summary

Eli Lilly provides an update on the Zyprexa Relprevv patient care program for schizophrenia, with enrollment ongoing by invitation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• ZYPREXA RELPREVV (olanzapine pamoate)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Schizophrenia | Status: ENROLLING_BY_INVITATION